首页> 美国卫生研究院文献>Journal of Clinical Oncology >Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801

【2h】

Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801

机译：生活质量取代局部晚期非小细胞肺癌长期生存的经典预后因素：RTOG 9801分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo determine the added value of quality of life (QOL) as a prognostic factor for overall survival (OS) in patients with locally advanced non–small-cell lung cancer (NSCLC) treated on Radiation Therapy Oncology Group RTOG-9801.

机译：目的确定通过放射治疗肿瘤学组RTOG-9801治疗的局部晚期非小细胞肺癌（NSCLC）患者的生活质量（QOL）增值作为总体生存（OS）的预后因素。

著录项

期刊名称 Journal of Clinical Oncology
作者
Benjamin Movsas; Jennifer Moughan; Linda Sarna; Corey Langer; Maria Werner-Wasik; Nicos Nicolaou; Ritsuko Komaki; Mitchell Machtay; Todd Wasserman; Deborah Watkins Bruner;
展开▼
作者单位

展开▼
年(卷),期 -1(27),34
年度 -1
页码 5816–5822
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. [J] . Movsas B, Moughan J, Sarna Journal of Clinical Oncology . 2009,第34期

机译：生活质量取代了局部晚期非小细胞肺癌长期生存的经典预后因素：RTOG 9801分析。
2. The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801 [J] . LawrenceY.R., PaulusR., LangerC., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2013,第3期

机译：在局部晚期非小细胞肺癌中向基于卡铂和紫杉醇的化学放疗中添加氨磷汀：放射治疗肿瘤学组（RTOG）的长期随访随机试验9801
3. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. [J] . Sarna L, Swann S, Langer C, International Journal of Radiation Oncology, Biology, Physics . 2009,第5期

机译：患者报告的氨磷汀联合化学放射治疗对局部晚期非小细胞肺癌的临床意义差异：RTOG 9801分析。
4. Multimodality Treatment of Locally-Advanced Breast Cancer Using 6.3 MeV Fast Neutrons and Quality of Life in Patients in Long-term Follow-up [C] . STARTSEVA Zhanna, MUSABAEVA Ludmila, LISIN Valerij International Conference on Physical-Technical Problems of Nuclear Science, Energy Generation and Power Industry . 2015

机译：在长期随访中使用6.3 MeV快速中子和患者生活质量的局部晚期乳腺癌的多模
5. Functional Status, Quality of Life, and Long-Term Survival in a Cohort of Women with Breast Cancer and Heart Failure: Results from the Medicare Health Outcomes Survey [D] . Harrison, Jordan M. 2017

机译：一组患有乳腺癌和心力衰竭的女性的功能状态，生活质量和长期生存：Medicare健康结果调查的结果
6. The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801 [O] . Lawrence Yaacov Richard, Paulus Rebecca, Langer Corey, -1

机译：在局部先进的非小细胞肺癌中添加氨基吡啶和基于紫杉醇的富紫外线的校长：放射治疗的长期随访肿瘤组（RTOG）随机试验9801
7. Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801 [O] . Movsas, Benjamin, Moughan, Jennifer, Sarna, Linda, 2009

机译：生活质量取代局部晚期非小细胞肺癌长期生存的经典预后因素：RTOG 9801分析

Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801

摘要

著录项

相似文献

相关主题

期刊订阅